Kiromic BioPharma, Inc. (KRBP)
OTCMKTS: KRBP · Delayed Price · USD
2.710
+0.070 (2.65%)
Apr 24, 2024, 3:38 PM EDT - Market closed

Kiromic BioPharma Market Cap

Kiromic BioPharma has a market cap or net worth of $3.49 million as of April 26, 2024. Its market cap has decreased by -47.10% in one year.

Market Cap
3.49M
Enterprise Value
15.83M
1-Year Change
-47.10%
Ranking
n/a
Category
Stock Price
$2.71

Market Cap Chart

Since the IPO on October 16, 2020, Kiromic BioPharma's market cap has decreased from $88.00M to $3.49M, a decrease of -96.03%. That is a compound annual growth rate of -67.01%.

History

DateMarket Cap% Change
Sep 13, 20231.70M-10.53%
Sep 12, 20231.90M5.56%
Sep 11, 20231.80M-
Sep 8, 20231.80M-
Sep 7, 20231.80M-5.26%
Sep 6, 20231.90M-13.64%
Sep 5, 20232.20M4.76%
Sep 1, 20232.10M-4.55%
Aug 31, 20232.20M4.76%
Aug 30, 20232.10M-8.70%
Aug 29, 20232.30M-
Aug 28, 20232.30M9.52%
Aug 25, 20232.10M-4.55%
Aug 24, 20232.20M-4.35%
Aug 23, 20232.30M-8.00%
Aug 22, 20232.50M-3.85%
Aug 21, 20232.60M-
Aug 18, 20232.60M-3.70%
Aug 17, 20232.70M-
Aug 16, 20232.70M-3.57%
Aug 15, 20232.80M-
Aug 14, 20232.80M27.27%
Aug 11, 20232.20M-4.35%
Aug 10, 20232.30M-
Aug 9, 20232.30M-
View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 708.98B
Novo Nordisk 559.94B
UnitedHealth Group 448.23B
Johnson & Johnson 360.41B
Merck & Co. 321.34B
AbbVie 300.20B
AstraZeneca 219.62B
Thermo Fisher 219.33B
Market Cap Rankings